retatrutide phase 3 trial dosage Eli Lilly's shows promising weight loss results in Retatrutide Dosage & Titration: Complete

Alzheimers Disease International: London, 2018

1 Despite growing adoption and inclusion in global guidelines recognizing obesity as a chronic disease requiring extended management, evidence on outcomes after cessation of GLP-1 therapy is limited and heterogeneous

Now, GLP-1 medications, such as Ozempic, Wegovy, and Mounjaro, are widely prescribed for weight management in people with overweight or obesity

People new to GLP-1 agonists If retatrutide is your first exposure to any GLP-1 receptor agonist, start at the lowest practical dose

"If you have struggled with your weight and been unable to keep off the weight you have lost in the past